Aminopeptidase activity plays a role in the metabolism of several pept
ides that could be involved in blood pressure control. This activity h
as been implicated in the pathogenesis of hypertension, essentially in
spontaneously hypertensive rats. However, few studies have examined a
minopeptidase activities in animal models other than genetic hypertens
ion. To analyze the aminopeptidase response to the specific conditions
of the reduced renal mass saline model of arterial hypertension, amin
opeptidase A activity (glutamyl-and aspartyl-aminopeptidase), aminopep
tidase M activity (alanyl-aminopeptidase), aminopeptidase B activity (
arginyl-aminopeptidase), pyroglutamyl-aminopeptidase and cystinyl-amin
opeptidase were measured in the neurohypophysis, in the adrenal gland
and in serum of this model of hypertension. In the neurohypophysis, th
ere was a significant increase of soluble cystinyl-, alanyl-, arginyl-
, pyroglutamyl- and membrane-bound aspartyl-aminopeptidase activities
in hypertensive animals. In the adrenal gland, soluble cystinyl-, alan
yl-, arginyl-and pyroglutamyl-aminopeptidase activities were also high
er in hypertensive rats than in normotensive controls. No differences
were found in serum levels of aminopeptidase activities between both g
roups of animals. A highly significant positive correlation between th
e neurohypophysis and the adrenal gland was observed for soluble cysti
nyl- and alanyl-aminopeptidase activities in the model of hypertension
, whereas no correlation was observed in normotensive rats. Our result
s suggest that aminopeptidase activities could be involved in the regu
latory response to the reduced renal mass hypertension and also sugges
t a coordinate response between the adrenal gland and the neurohypophy
sis, to the specific metabolic conditions of this model of hypertensio
n.